Re-envisioning clinical trial design in systemic sclerosis

By sjmartinez • May 10, 2025

Volkmann ER, Tashkin DP, Smith V. Re-envisioning clinical trial design in systemic sclerosis. Expert Rev Clin Immunol. 2025 May 8. doi: 10.1080/1744666X.2025.2500612. Epub ahead of print. PMID: 40339169.

Tags: clinical trials, controlled clinical trials, discovery, Publications, Pulmonary, Critical Care & Sleep Medicine, randomized, Rheumatology, Scleroderma, systemic sclerosis

Related Posts

Integrating long-acting injectable cabotegravir for HIV prevention into the Brazilian public health system ImPrEP CAB Brasil: a hybrid type-2 implementation-effectiveness cohort study

Grinsztejn B, Torres TS, Hoagland B, Coutinho C, Silva MST, Leite IC, Cunha M, Derrico M, Jalil EM, Cardoso SW, Trefiglio R, Farias A, Mourão[...]

Getting to best practice: a practice-oriented checklist for monitoring clinic-level fidelity to hypertension interventions in a large safety-net healthcare system

Korn AR, Gandhi P, R Dopp A, Barron J, Casillas-Salazar R, Durant C, G Morales M, Norwood-Scott E, L Carson S, Casillas A, B Hamilton[...]

Air Pollution Triggers Metabolomic Signature of Mitochondrial Dysfunction in Mice and Humans: Implications for Cardiovascular Disease Development

Lin Y, Qiu X, Gupta R, Ramanathan G, Lu X, Yin F, Fiehn O, Zhang JJ, Kaufman JD, Zhu Y, Rosenfeld M, Araujo JA. Air[...]